Endocrinology News and Research

Latest Endocrinology News and Research

New York Times examines possible entry into global market of generic drugs for NCDs

The New York Times describes how, as the U.N. begins its meeting on non-communicable diseases (NCDs), Chinese and Indian generic drug makers "say they are on the verge of selling cheaper copies" of costly biotech medications used to treat cancers, diabetes, arthritis and other chronic illnesses.

20 Sep 2011

WHO, WEF reports examine cost of treating and preventing, economic burden of NCDs

Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.

20 Sep 2011

NCD draft declaration lacks specific targets, calls for nations to adopt recommendations for reducing chronic disease deaths

"World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable 'lifestyle' diseases," including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), "amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries," the Guardian reports.

20 Sep 2011

NYU Langone creates new Joan H. Tisch Center for Women's Health in New York City

NYU Langone Medical Center announced the establishment of its new Joan H. Tisch Center for Women's Health on the Upper East Side of Manhattan in New York City.

20 Sep 2011

People with diabetes more likely to develop dementia

People with diabetes appear to be at a significantly increased risk of developing dementia, according to a study published in the September 20, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

20 Sep 2011

Common misconceptions about Alzheimer's disease

Alzheimer's disease, the most common form of dementia, continues to be an ongoing battle for millions of Americans. With an estimated 5.4 million Americans living with the disease and an annual cost of $183 billion, Dr. Gustavo C. Roman, director of the Nantz National Alzheimer Center at the Methodist Neurological Institute, addresses some common misconceptions about this devastating disease.

20 Sep 2011

UNC researchers reveal genetic underpinnings of Foxp3-expressing regulatory T cells

Within the immune system, a subtle balance exists between the cells that destroy alien pathogens and those that preserve the body's own tissues. When the balance gets out of whack, the cells that normally target viruses or bacteria can go astray, attacking innocent cells and causing autoimmune and inflammatory disease.

20 Sep 2011

Roxon plans to propagate tough stands on tobacco packaging

Health Minister Nicola Roxon plans to encourage other countries to follow Australia's push for plain-packaged tobacco at a major United Nations summit on chronic diseases today.

19 Sep 2011

Chronic diseases could cost $47 trillion over the next 20 years: Report

A latest report by the World Economic Forum (WEF) suggests that the global economic impact of the five leading chronic diseases -- cancer, diabetes, mental illness, heart disease, and respiratory disease - could reach $47 trillion over the next 20 years.

19 Sep 2011

High dietary salt intake and obesity together trigger abnormal activation of cellular protein

Dietary salt intake and obesity are two important risk factors in the development of high blood pressure. Each packs its own punch, but when combined, they deliver more damage to the heart and kidneys than the sum of their individual contributions.

19 Sep 2011

Prevalence of diabetes increases 30% over last four years in urban India

The prevalence of diabetes in urban India is accelerating at a rapid rate and now stands at 5.5 percent (just under 20 million people), compared with 4.6 percent in 2007 - equivalent to a 30 percent increase in actual population numbers over the last four years - according to new research by GfK HealthCare's Roper Global Diabetes Group. Moreover, a full 10 percent of these patients have been diagnosed in the past 12 months.

19 Sep 2011

Tarsa reports positive data from OSTORA Phase III ORACAL trial for postmenopausal osteoporosis

Tarsa Therapeutics today reported that it presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

19 Sep 2011

OptiScan's new bedside glucose monitoring system receives European CE Mark

OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the company's OptiScanner Automatic Bedside Glucose Monitoring System has received CE Mark certification for use in the European Union.

19 Sep 2011

Aestus to develop ATx09-002 for treatment of neuropathic pain

Aestus Therapeutics, Inc. and Prosidion Ltd., a wholly owned subsidiary of Astellas Pharma Inc., announced today a license agreement providing Aestus with exclusive, world-wide rights to the Prosidion investigational product PSN-357.

19 Sep 2011

ESC urges European heads of state to prevent chronic non-communicable diseases

The European Society of Cardiology, through the European Chronic Disease Alliance (ECDA), has urged European heads of state "to show leadership" and long-term commitment to the prevention of chronic non-communicable diseases at today's "high level meeting" of the UN General Assembly in New York.

19 Sep 2011

NeuroVive, Selcia sign research collaboration agreement to develop new mitochondrial drugs

UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.

19 Sep 2011

NTNU genetic research shows best recipe to limit risk of lifestyle-related diseases

What should we eat? Answers abound in the international media, all of which rely on their interpretation of recent medical literature to come up with recommendations for the healthiest diet. But what if you could answer this question at a molecular level - what if you could find out how our genes respond to the foods we eat, and what this does to the cellular processes that make us healthy - or not? That's precisely what biologists at the Norwegian University of Science and Technology have done.

19 Sep 2011

Two newer Type 2 diabetes drugs could be linked to increased risk of pancreatic cancer

Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according to a new UCLA study.

19 Sep 2011

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

19 Sep 2011

Roundup: San Diego launches new HIV testing effort; Study finds economy hurt by Mass. health law; Texas schools turning to safe sex curriculum

The Centers for Disease Control says 20 percent of Americans with HIV don't know they're infected, and those people are responsible for about half of all new infections. A new effort in San Diego is trying to reduce those numbers by making HIV testing more widespread.

17 Sep 2011

Endocrinology News and Research

Latest Endocrinology News and Research

New York Times examines possible entry into global market of generic drugs for NCDs

WHO, WEF reports examine cost of treating and preventing, economic burden of NCDs

NCD draft declaration lacks specific targets, calls for nations to adopt recommendations for reducing chronic disease deaths

NYU Langone creates new Joan H. Tisch Center for Women's Health in New York City

People with diabetes more likely to develop dementia

Common misconceptions about Alzheimer's disease

UNC researchers reveal genetic underpinnings of Foxp3-expressing regulatory T cells

Roxon plans to propagate tough stands on tobacco packaging

Chronic diseases could cost $47 trillion over the next 20 years: Report

High dietary salt intake and obesity together trigger abnormal activation of cellular protein

Prevalence of diabetes increases 30% over last four years in urban India

Tarsa reports positive data from OSTORA Phase III ORACAL trial for postmenopausal osteoporosis

OptiScan's new bedside glucose monitoring system receives European CE Mark

Aestus to develop ATx09-002 for treatment of neuropathic pain

ESC urges European heads of state to prevent chronic non-communicable diseases

NeuroVive, Selcia sign research collaboration agreement to develop new mitochondrial drugs

NTNU genetic research shows best recipe to limit risk of lifestyle-related diseases

Two newer Type 2 diabetes drugs could be linked to increased risk of pancreatic cancer

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

Roundup: San Diego launches new HIV testing effort; Study finds economy hurt by Mass. health law; Texas schools turning to safe sex curriculum

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Endocrinology News and Research

Latest Endocrinology News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in